Prevalence of Metabolic Syndrome in Schizophrenic Patients

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Medical Journal of Babylon

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Association study of polymorphisms in leptin and leptin receptor genes with antipsychotic-induced body weight gain.

  2012cited by this paper
• Is antipsychotic polypharmacy associated with metabolic syndrome even after adjustment for lifestyle effects?: a cross-sectional study

  2011cited by this paper
• Evidence-Based Perspective on Metabolic Syndrome and Use of Antipsychotics

  2010cited by this paper
• Potential mechanisms of atypical antipsychotic-induced metabolic derangement: clues for understanding obesity and novel drug design.

  2010cited by this paper
• Prevalence of metabolic syndrome among Australians with severe mental illness

  2009cited by this paper
• Prevalence of Metabolic Syndrome among an Iranian Cohort of Inpatients with Schizophrenia

  2009cited by this paper
• Hypoadiponectinemia: a risk factor for metabolic syndrome.

  2009cited by this paper
• Risk Factors of Metabolic Syndrome among Egyptian Patients with Schizophrenia

  2008cited by this paper
• [The prevalence of metabolic syndrome and related factors in patients with schizophrenia].

  2008cited by this paper
• Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease

  2007cited by this paper
• Clinical Practice and Epidemiology in Mental Health

  2007cited by this paper
• Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study.

  2006cited by this paper
• Dyslipidaemia, hypercoagulability and the metabolic syndrome.

  2006cited by this paper
• Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

  2006cited by this paper
• Differential metabolic effects of antipsychotic treatments.

  2006cited by this paper
• Metabolic Syndrome and 10-Year Cardiovascular Disease Risk in the Hoorn Study

  2005cited by this paper
• The metabolic syndrome--a new worldwide definition.

  2005cited by this paper
• Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence.

  2005cited by this paper
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

  2004cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Inflammation, the metabolic syndrome and cardiovascular risk.

  2003cited by this paper
• Adrenocortical, Autonomic, and Inflammatory Causes of the Metabolic Syndrome: Nested Case-Control Study

  2002cited by this paper
• Factor analysis of metabolic syndrome using directly measured insulin sensitivity: The Insulin Resistance Atherosclerosis Study.

  2002cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress.

  2002cited by this paper
• Hypothalamic-Pituitary-Adrenal Axis Function and the Metabolic Syndrome X of Obesity

  2001cited by this paper
• The hypothalamic–pituitary–adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke

  2000cited by this paper
• The unhealthy lifestyle of people with schizophrenia

  1999cited by this paper
• Comment on the provisional report from the WHO consultation

  1999cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• Harrison's Principles of Internal Medicine

  1988cited by this paper

• Antipsychotic Polypharmacy and Its Relation to Metabolic Syndrome in Patients With Schizophrenia: An Egyptian Study

  2017cites this paper
• A meta‐analysis of cardio‐metabolic abnormalities in drug naïve, first‐episode and multi‐episode patients with schizophrenia versus general population controls

  2013cites this paper